Leap Therapeutics, Inc.
LPTX
$0.377
-$0.0134-3.43%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 32.71M | 47.25M | 62.82M | 78.48M | 54.92M |
| Total Receivables | 711.00K | 704.00K | 780.00K | 754.00K | 738.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 446.00K | 86.00K | 209.00K | 354.00K | 526.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 33.87M | 48.04M | 63.81M | 79.59M | 56.19M |
|
|
|||||
| Total Current Assets | 33.87M | 48.04M | 63.81M | 79.59M | 56.19M |
| Net Property, Plant & Equipment | 152.00K | 262.00K | 370.00K | 475.00K | 577.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 857.00K | 823.00K | 865.00K | 1.36M | 1.20M |
| Total Assets | 34.88M | 49.12M | 65.05M | 81.43M | 57.96M |
|
|
|||||
| Total Accounts Payable | 6.36M | 4.74M | 5.95M | 7.81M | 5.95M |
| Total Accrued Expenses | 6.99M | 8.54M | 9.05M | 7.35M | 4.06M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 154.00K | 266.00K | 376.00K | 443.00K | 430.00K |
| Total Finance Division Other Current Liabilities | 536.00K | 531.00K | 722.00K | -- | -- |
| Total Other Current Liabilities | 536.00K | 531.00K | 722.00K | -- | -- |
| Total Current Liabilities | 14.04M | 14.08M | 16.09M | 15.60M | 10.44M |
|
|
|||||
| Total Current Liabilities | 14.04M | 14.08M | 16.09M | 15.60M | 10.44M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 39.00K | 154.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 14.04M | 14.08M | 16.09M | 15.64M | 10.59M |
|
|
|||||
| Common Stock & APIC | 503.76M | 502.54M | 500.89M | 499.55M | 460.89M |
| Retained Earnings | -482.81M | -467.37M | -451.94M | -433.76M | -413.40M |
| Treasury Stock & Other | -113.00K | -120.00K | 6.00K | 3.00K | -120.00K |
| Total Common Equity | 20.84M | 35.05M | 48.95M | 65.79M | 47.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 20.84M | 35.05M | 48.95M | 65.79M | 47.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.84M | 35.05M | 48.95M | 65.79M | 47.37M |
|
|
|||||